Terms: = Liver cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Prognosis
11 results:
1. ABI2-mediated MEOX2/klf4-NANOG axis promotes liver cancer stem cell and drives tumour recurrence.
Chen J; Li H; Zhang B; Xiong Z; Jin Z; Chen J; Zheng Y; Zhu X; Zhang S
Liver Int; 2022 Nov; 42(11):2562-2576. PubMed ID: 36017822
[TBL] [Abstract] [Full Text] [Related]
2. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
[TBL] [Abstract] [Full Text] [Related]
3. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract] [Full Text] [Related]
4. AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.
Bian X; Shi D; Xing K; Zhou H; Lu L; Yu D; Wu W
Clin Transl Med; 2021 Mar; 11(3):e352. PubMed ID: 33783988
[TBL] [Abstract] [Full Text] [Related]
5. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract] [Full Text] [Related]
6. The association between klf4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection.
Xue M; Zhou C; Zheng Y; Zhang Z; Wang S; Fu Y; Atyah M; Xue X; Zhu L; Dong Q; Jia H; Ren N; Hu R
Aging (Albany NY); 2020 Aug; 12(15):15566-15580. PubMed ID: 32756012
[TBL] [Abstract] [Full Text] [Related]
7. TRAF7 enhances ubiquitin-degradation of klf4 to promote hepatocellular carcinoma progression.
He H; Wu Z; Li S; Chen K; Wang D; Zou H; Chen H; Li Y; Liu Z; Qu C
Cancer Lett; 2020 Jan; 469():380-389. PubMed ID: 31730901
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA‑9‑5p downregulates klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract] [Full Text] [Related]
9. RYBP Expression Is Regulated by klf4 and Sp1 and Is Related to Hepatocellular Carcinoma prognosis.
Zhao Q; Cai W; Zhang X; Tian S; Zhang J; Li H; Hou C; Ma X; Chen H; Huang B; Chen D
J Biol Chem; 2017 Feb; 292(6):2143-2158. PubMed ID: 28028181
[TBL] [Abstract] [Full Text] [Related]
10. The Novel klf4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract] [Full Text] [Related]
11. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and klf4.
Chen HY; Lin YM; Chung HC; Lang YD; Lin CJ; Huang J; Wang WC; Lin FM; Chen Z; Huang HD; Shyy JY; Liang JT; Chen RH
Cancer Res; 2012 Jul; 72(14):3631-41. PubMed ID: 22593189
[TBL] [Abstract] [Full Text] [Related]
